BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29725448)

  • 21. Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma.
    Yang Y; Niu X; Liu W; Xu H
    Oncol Lett; 2017 Nov; 14(5):5491-5496. PubMed ID: 29142603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
    Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
    Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Serum SPARC Levels on Survival in Patients with Digestive Tract Cancer: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial.
    Akutsu T; Ito E; Narita M; Ohdaira H; Suzuki Y; Urashima M
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32512862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection.
    Hashimoto I; Kimura Y; Oue N; Hiroshima Y; Aoyama T; Rino Y; Yokose T; Yasui W; Miyagi Y; Oshima T
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and prognostic significance of SPARC expression in gastric cancer: A meta‑analysis and bioinformatics analysis.
    Sun J; Bai YK; Fan ZG
    Oncol Lett; 2023 Jun; 25(6):240. PubMed ID: 37181948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
    Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
    Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
    Fujitani K; Kurokawa Y; Takeno A; Endoh S; Ohmori T; Fujita J; Yamasaki M; Takiguchi S; Mori M; Doki Y;
    Gastric Cancer; 2018 May; 21(3):446-452. PubMed ID: 28965205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the
    Kano K; Sakamaki K; Oue N; Kimura Y; Hashimoto I; Hara K; Maezawa Y; Aoyama T; Fujikawa H; Hiroshima Y; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Cho H; Ito H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Yasui W; Masuda M; Miyagi Y; Oshima T
    In Vivo; 2020; 34(1):461-467. PubMed ID: 31882514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between stromal cell derived SPARC in human gastric cancer tissue and its clinicopathologic significance.
    Gao Y; Yin SP; Xie XS; Xu DD; Du WD
    Oncotarget; 2017 Oct; 8(49):86240-86252. PubMed ID: 29156791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
    Namikawa T; Maeda H; Kitagawa H; Oba K; Tsuji A; Yoshikawa T; Kobayashi M; Hanazaki K
    BMC Cancer; 2018 Feb; 18(1):186. PubMed ID: 29439671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of SPARC expression in pancreatic cancer progression and patient survival.
    Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
    Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer.
    Tsujimoto H; Horiguchi H; Hiraki S; Yaguchi Y; Takahata R; Kumano I; Yoshida K; Matsumoto Y; Ono S; Yamamoto J; Hase K
    Oncol Lett; 2012 Nov; 4(5):1135-1139. PubMed ID: 23162667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of secreted protein acidic and rich in cysteine is an independent prognostic indicator of a poor clinical outcome in oropharyngeal carcinoma patients.
    Yoshida S; Wakisaka N; Kondo S; Moriyama-Kita M; Hirai N; Endo K; Tsuji A; Nakanishi Y; Murono S; Yoshizaki T
    Acta Otolaryngol; 2016; 136(2):189-94. PubMed ID: 26523779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
    Wu J; Zhang JR; Jiang XQ; Cao XG
    Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
    Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
    Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
    Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
    Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
    Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
    Jiang X; Liu F; Wang Y; Gao J
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secreted Protein Acidic and Rich in Cysteine (
    Arqueros C; Salazar J; Gallardo A; Andrés M; Tibau A; Lidia Bell O; Artigas A; Lasa A; Ramón Y Cajal T; Lerma E; Barnadas A
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.